Tony Murphy was a solid 20-a-day smoker. His attempts at quitting lasted at best days, often only hours, as his craving for a ...

Despite a crowded GLP-1 drug development field, Structure's oral small molecule approach and strong financial position offer ...

Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India. Here's what ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

BRP, identified through peptide prediction, may revolutionize weight loss treatment, offering efficacy without the ...

BRP emerges as a promising peptide for weight loss, activating appetite control pathways without triggering nausea, paving ...

Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose ...

BRINP2-related peptide, or BRP, is a naturally occurring molecule that can suppress appetite and promote weight loss in mice ...

Scientists at Stanford Medicine have discovered a naturally occurring molecule, BRP, which aids in weight loss while avoiding the side effects associated with drugs like Ozempic. This molecule targets ...

Stanford Medicine scientists have tested a naturally occurring molecule; the best part of the study is it cancels the side effects. It has been nicknamed BRP and offers a 'more targeted approach to ...

Scientists have discovered a naturally occurring molecule that aids appetite control and weight loss so well, it may compete ...

Scientists have discovered a naturally-occurring molecule that rivals the weight-loss effects of semaglutide-based GLP-1s like Ozempic in animals.